Slovenia's Lek Registers Drugs for Parkinsons Disease in the U.S.

Ljubljana, 31 January - The U.S. Food and Drug Administration on 28 January gave the green light to the Slovene company Lek to sell on the U.S. market bromokriptin in the form of tablets, a medicine curing Parkinsons disease, Lek said on Thursday.